Dry Cracked Skin
Impetigo
Aesthetics
Vitiligo
COVID-19
Actinic Keratosis
Precision Medicine and Biologics
Rare Disease
Wound Care
Rosacea
Psoriasis
Psoriatic Arthritis
Atopic Dermatitis
Surgery
Melasma
NP and PA
Anti-Aging
Skin Cancer
Hidradenitis Suppurativa
Drug Watch
Pigmentary Disorders
Acne
Pediatric Dermatology
Practice Management
Inflamed Skin

Clinical Experiences of Using Circulating Tumor DNA

Name: Clinical Experiences of Using Circulating Tumor DNA
Uploaded: 2022-04-01T15:00:00.000Z
Description: In this third part of a 4 part video series, Lisa Zaba, MD, PhD, FAAD, highlights the in practice experiences in using circulating tumor DNA for merkel cell carcinoma (MCC).

April 1, 2022

Mary Scoviak, Managing Editor

Video

Conference|American Academy of Dermatology

In this third part of a 4 part video series, Lisa Zaba, MD, PhD, FAAD, highlights the in practice experiences in using circulating tumor DNA for merkel cell carcinoma (MCC).